CDRT15L inhibitors are a class of compounds designed to specifically inhibit the activity of the CDRT15-like protein (CDRT15L), a protein implicated in cellular processes related to gene expression and intracellular signaling. While CDRT15L's specific biological functions are still being elucidated, it is thought to be involved in the regulation of transcriptional activity and protein-protein interactions. By inhibiting CDRT15L, these compounds disrupt its ability to interact with key molecular partners, leading to alterations in cellular pathways associated with gene regulation and intracellular communication. This inhibition is critical for studying how CDRT15L influences cellular dynamics and controls specific transcriptional or signaling events.
The mechanism of CDRT15L inhibitors typically involves binding to functional domains within the protein, blocking its interactions with other proteins or DNA sequences that it may regulate. This interference allows researchers to probe the specific roles that CDRT15L plays in cellular physiology and to investigate the downstream effects of its inhibition on gene expression and signal transduction pathways. CDRT15L inhibitors are valuable tools for understanding the broader regulatory networks that involve this protein, particularly in terms of how it influences transcriptional processes and cellular responses to various stimuli. By modulating the activity of CDRT15L, scientists can gain insights into its contributions to cellular organization, gene expression patterns, and how the inhibition of this protein impacts broader biological processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interacts with DNA and hinders RNA polymerase action, potentially decreasing transcription of various genes. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Specifically inhibits RNA polymerase II, which is essential for mRNA synthesis, possibly affecting protein expression. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Binds to bacterial RNA polymerase and inhibits RNA synthesis, used in research for studying transcriptional inhibition. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Blocks the translocation step in eukaryotic protein synthesis, which can lead to reduced overall protein levels. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Causes premature chain termination during translation in eukaryotes, which could decrease protein synthesis. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylase, affecting chromatin structure and transcription regulation, potentially reducing gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, altering the methylation status of DNA and potentially affecting gene expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibits topoisomerase I, affecting DNA replication and transcription, potentially reducing protein expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Targets topoisomerase II, leading to DNA damage and potential alterations in gene expression profiles. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can influence cell cycle and gene expression by altering protein degradation pathways. | ||||||